TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib,Journal of Contemporary Brachytherapy

当前位置： X-MOL 学术 › J. Contemp. Brachyther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
Journal of Contemporary Brachytherapy ( IF 1.4 ) Pub Date : 2023-08-31 , DOI: 10.5114/jcb.2023.131239
Cheng Lin ₁ , Chen Chen ₁ , Guiliu Huang ₂ , Yueyong Li ₁ , Lifeng Zhao ₃ , Zhongheng Wei ₄

Affiliation

Few cases of patients with Cheng’s type III portal vein tumor thrombus (PVTT) have been reported to achieve radical cure without recurrence over time. In this study, we reported on a 55-year-old male patient with a diagnosis of stage IIIa China liver cancer staging (CNLC), PVTT Cheng’s type III, mild cirrhosis, and chronic viral hepatitis B. TACE combined with radioactive iodine-125 (¹²⁵I) particle implantation was applied to achieve radical treatment with sequential oral anlotinib hydrochloride capsules. This case might serve as a reference for the treatment of this disease.

更新日期：2023-08-31

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>